Nephrology
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that...
Conference Coverage
Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR
Another dimension of dapagliflozin’s renal protection for type 2 diabetes patients is shown in a post-hoc analysis from its cardiovascular...
News
Large COVID-19 dataset: Kidney injury in >35% of those in hospital
The clearest risk factors for the development of AKI were “the need for ventilator support or vasopressor drug treatment.”
News
Dapagliflozin trial in CKD halted because of high efficacy
An independent data monitoring committee recommended stopping the trial.
News
Smoking, hypoglycemia, kidney function tied to vision loss in type 2 diabetes
Smoking cessation and management strategies to avoid severe hypoglycemia and preserve kidney function may offset vision loss in patients with...
News
Stillbirth linked to end-stage renal disease
There was also an association between stillbirth and risk for chronic kidney disease.
Renal Consult
When Should I Refer My CKD Patient to Nephrology?
Here’s what the research suggests for when to consider referring a patient with chronic kidney disease to a specialist.
Conference Coverage
Children with resistant UTIs unexpectedly may respond to discordant antibiotics
A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities...
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.